List of Contents

Medical Foods Market Size, Share, and Trends 2024 to 2034

The global medical foods market size is calculated at USD 26.07 billion in 2025 and is forecasted to reach around USD 40.74 billion by 2034, accelerating at a CAGR of 5.09% from 2025 to 2034. The North America medical foods market size surpassed USD 7.94 billion in 2024 and is expanding at a CAGR of 5.13% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 4244
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Foods Market 

5.1. COVID-19 Landscape: Medical Foods Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Foods Market, By Route of Administration

8.1. Medical Foods Market Revenue and Volume Forecast, by Route of Administration

8.1.1. Oral

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Enteral

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Medical Foods Market, By Application

9.1. Medical Foods Market Revenue and Volume Forecast, by Application

9.1.1. Chronic Kidney Disease

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Minimal Hepatic Encephalopathy

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Chemotherapy-induced Diarrhoea

9.1.3.1. Market Revenue and Volume Forecast

9.1.5. Pathogen-related Infections

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Diabetic Neuropathy

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Adhd

9.1.7.1. Market Revenue and Volume Forecast

9.1.8. Depression

9.1.8.1. Market Revenue and Volume Forecast

9.19. Alzheimer's Disease

9.1.9.1. Market Revenue and Volume Forecast

9.1.10. Nutritional Deficiency

9.1.10.1. Market Revenue and Volume Forecast

9.1.11. Orphan Diseases

9.1.11.1. Market Revenue and Volume Forecast

9.1.12. Wound Healing

9.1.12.1. Market Revenue and Volume Forecast

9.1.13. Chronic Diarrhea

9.1.13.1. Market Revenue and Volume Forecast

9.1.14. Constipation Relief

9.1.14.1. Market Revenue and Volume Forecast

9.1.15. Protein Booster

9.1.15.1. Market Revenue and Volume Forecast

9.1.16. Dysphagia

9.1.16.1. Market Revenue and Volume Forecast

9.1.17. Pain Management

9.1.17.1. Market Revenue and Volume Forecast

9.1.18. Parkinson's Disease

9.1.18.1. Market Revenue and Volume Forecast

9.1.19. Epilepsy

9.1.19.1. Market Revenue and Volume Forecast

9.1.20. Other cancer-related Treatments

9.1.20.1. Market Revenue and Volume Forecast

9.1.21. Severe protein Allergy

9.1.21.1. Market Revenue and Volume Forecast

9.1.22. Cancer

9.1.22.1. Market Revenue and Volume Forecast

9.1.23. Cachexia

9.1.23.1. Market Revenue and Volume Forecast

9.1.24. Other

9.1.24.1. Market Revenue and Volume Forecast

Chapter 11. Global Medical Foods Market, By Sales Channel 

10.1. Medical Foods Market Revenue and Volume Forecast, by Sales Channel

10.1.1. Online Sales

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Retail Sales

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Institutional Sales

10.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Medical Foods Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Route of Administration

12.1.2. Market Revenue and Volume Forecast, by Application

12.1.3. Market Revenue and Volume Forecast, by Sales Channel

12.1.4. Market Revenue and Volume Forecast, by April

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.1.5.2. Market Revenue and Volume Forecast, by Application

12.1.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.1.5.4. Market Revenue and Volume Forecast, by April

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Route of Administration

12.1.6.2. Market Revenue and Volume Forecast, by Application

12.1.6.3. Market Revenue and Volume Forecast, by Sales Channel

12.1.6.4. Market Revenue and Volume Forecast, by April

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Route of Administration

12.2.2. Market Revenue and Volume Forecast, by Application

12.2.3. Market Revenue and Volume Forecast, by Sales Channel

12.2.4. Market Revenue and Volume Forecast, by April

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.2.5.2. Market Revenue and Volume Forecast, by Application

12.2.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.2.5.4. Market Revenue and Volume Forecast, by April

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Route of Administration

12.2.6.2. Market Revenue and Volume Forecast, by Application

12.2.6.3. Market Revenue and Volume Forecast, by Sales Channel

12.2.6.4. Market Revenue and Volume Forecast, by April

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Route of Administration

12.2.7.2. Market Revenue and Volume Forecast, by Application

12.2.7.3. Market Revenue and Volume Forecast, by Sales Channel

12.2.7.4. Market Revenue and Volume Forecast, by April

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Route of Administration

12.2.8.2. Market Revenue and Volume Forecast, by Application

12.2.8.3. Market Revenue and Volume Forecast, by Sales Channel

12.2.8.4. Market Revenue and Volume Forecast, by April

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Route of Administration

12.3.2. Market Revenue and Volume Forecast, by Application

12.3.3. Market Revenue and Volume Forecast, by Sales Channel

12.3.4. Market Revenue and Volume Forecast, by April

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.3.5.2. Market Revenue and Volume Forecast, by Application

12.3.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.3.5.4. Market Revenue and Volume Forecast, by April

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Route of Administration

12.3.6.2. Market Revenue and Volume Forecast, by Application

12.3.6.3. Market Revenue and Volume Forecast, by Sales Channel

12.3.6.4. Market Revenue and Volume Forecast, by April

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Route of Administration

12.3.7.2. Market Revenue and Volume Forecast, by Application

12.3.7.3. Market Revenue and Volume Forecast, by Sales Channel

12.3.7.4. Market Revenue and Volume Forecast, by April

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Route of Administration

12.3.8.2. Market Revenue and Volume Forecast, by Application

12.3.8.3. Market Revenue and Volume Forecast, by Sales Channel

12.3.8.4. Market Revenue and Volume Forecast, by April

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Route of Administration

12.4.2. Market Revenue and Volume Forecast, by Application

12.4.3. Market Revenue and Volume Forecast, by Sales Channel

12.4.4. Market Revenue and Volume Forecast, by April

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.4.5.2. Market Revenue and Volume Forecast, by Application

12.4.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.4.5.4. Market Revenue and Volume Forecast, by April

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Route of Administration

12.4.6.2. Market Revenue and Volume Forecast, by Application

12.4.6.3. Market Revenue and Volume Forecast, by Sales Channel

12.4.6.4. Market Revenue and Volume Forecast, by April

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Route of Administration

12.4.7.2. Market Revenue and Volume Forecast, by Application

12.4.7.3. Market Revenue and Volume Forecast, by Sales Channel

12.4.7.4. Market Revenue and Volume Forecast, by April

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Route of Administration

12.4.8.2. Market Revenue and Volume Forecast, by Application

12.4.8.3. Market Revenue and Volume Forecast, by Sales Channel

12.4.8.4. Market Revenue and Volume Forecast, by April

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.5.2. Market Revenue and Volume Forecast, by Application

12.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.5.4. Market Revenue and Volume Forecast, by April

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Route of Administration

12.5.5.2. Market Revenue and Volume Forecast, by Application

12.5.5.3. Market Revenue and Volume Forecast, by Sales Channel

12.5.5.4. Market Revenue and Volume Forecast, by April

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Route of Administration

12.5.6.2. Market Revenue and Volume Forecast, by Application

12.5.6.3. Market Revenue and Volume Forecast, by Sales Channel

12.5.6.4. Market Revenue and Volume Forecast, by April

Chapter 13. Company Profiles

13.1. Danone

13.1.1. Company Overview

13.1.2. Application Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Nestlé

13.2.1. Company Overview

13.2.2. Application Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Abbott

13.3.1. Company Overview

13.3.2. Application Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Targeted Medical Pharma Inc.

13.4.1. Company Overview

13.4.2. Application Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Primus Pharmaceuticals Inc.

13.5.1. Company Overview

13.5.2. Application Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Fresenius Kabi AG

13.6.1. Company Overview

13.6.2. Application Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Mead Johnson & Company, LLC

13.7.1. Company Overview

13.7.2. Application Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global medical foods market size is expected to increase USD 40.74 billion by 2034 from USD 24.80 billion in 2024.

The global medical foods market will register growth rate of 5.09% between 2025 and 2034.

The major players operating in the medical foods market are Danone, Nestlé, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC and Othrs. Segments Covered in the Report

The driving factors of the medical foods market are the rising prevalence of chronic diseases and growing geriatric population.

North America region will lead the global medical foods market during the forecast period 2025 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us